MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Genetic testing is crucial for diagnosing ICF3 syndrome, aiding early detection, tailored treatment, and informed family planning by identifying specific genetic mutations.
Explore the role of genetic testing in diagnosing and managing ICF4, offering early diagnosis, personalized treatments, and informed family planning options.
Explore inherited oocyte maturation defect, a rare infertility cause, and the role of genetic testing in diagnosis, family planning, and personalized medicine.
Explore how genetic testing, including prenatal and postnatal options, aids in diagnosing and managing Intellectual Disability, Autosomal Dominant 41.
Explore the benefits of genetic testing in diagnosing Intellectual Disability, Autosomal Dominant 42. Learn about early detection, personalized treatments, and family planning.
Diagnose IDAD43 early with genetic testing. Understand SETBP1 mutations, plan personalized care, and improve outcomes for intellectual disability management.
Genetic testing is pivotal in diagnosing IDAR51, offering early intervention, informed family planning, and advancing research for targeted therapies and better outcomes.
Explore how genetic testing for Intellectual Disability, Autosomal Recessive 52 aids diagnosis, offers insights for personalized care, and assists in family planning.